IL-11
IL-11 Brand names, IL-11 Analogs
IL-11 Brand Names Mixture
- No information avaliable
IL-11 Chemical_Formula
C854H1411N253O235S2
IL-11 RX_link
http://www.rxlist.com/cgi/generic3/oprelvek.htm
IL-11 fda sheet
IL-11 msds (material safety sheet)
IL-11 Synthesis Reference
No information avaliable
IL-11 Molecular Weight
19047.2
IL-11 Melting Point
No information avaliable
IL-11 H2O Solubility
No information avaliable
IL-11 State
Liquid
IL-11 LogP
-0.070
IL-11 Dosage Forms
Powder for solution; Solution (subcutaneous injection)
IL-11 Indication
Increases reduced platelet levels due to chemotherapy
IL-11 Pharmacology
Oprelvekin is indicated for the prevention of severe thrombocytopenia and the reduction of the need for platelet transfusions following myelosuppressive chemotherapy in adult patients with nonmyeloid malignancies who are at high risk of severe thrombocytopenia. The primary hematopoietic activity of Oprelvekin is stimulation of megakaryocytopoiesis and thrombopoiesis. Oprelvekin has shown potent thrombopoietic activity in individuals with compromised hematopoiesis
IL-11 Absorption
No information avaliable
IL-11 side effects and Toxicity
No information avaliable
IL-11 Patient Information
No information avaliable
IL-11 Organisms Affected
Humans and other mammals
